section name header

Y-Site Injection Compatibility (1:1 Mixture)

Fat emulsion, intravenous

(Conc: TNA #218 to #226c)

I

Doxorubicin HCl

(Mfr: PH, GEN)(Conc: 2 mg/mL)

Remarks:

Damage to emulsion occurs immediately with free oil formation possible

Ref:

2215